A patient with a recent diagnosis of Stage II invasive melanoma is scheduled for a sentinel lymph node biopsy. As the nurse, what is the most important consideration when preparing the patient for this procedure?

A) Ensure the patient understands the purpose of the biopsy and potential outcomes.

B) Discuss the dietary restrictions the day before the procedure.

C) Educate the patient on the signs of infection post-procedure.

D) Confirm the patient has arranged transportation home post-procedure.

A patient with confirmed Stage II invasive melanoma is scheduled for a sentinel lymph node biopsy. Which nursing intervention is most important in preparing the patient for this procedure?

D) Verifying that the patient has discontinued any anticoagulant medications as instructed

A) Educating the patient about potential changes in body image post-surgery

B) Ensuring the patient understands the importance of fasting prior to the procedure

C) Assessing the patient's understanding of the possible need for adjuvant therapy

D) Verifying that the patient has discontinued any anticoagulant medications as instructed

A patient with a history of melanoma now presents with worsening fatigue, left axillary lymphadenopathy, skin discoloration, and a slight fever. Which nursing intervention is most appropriate to prioritize at this time?

C) Prepare the patient for an expedited sentinel lymph node biopsy.

A) Administer antipyretics to address the patient's fever.

B) Educate the patient about the importance of reporting new skin changes.

C) Prepare the patient for an expedited sentinel lymph node biopsy.

D) Initiate dietary assessment to address the patient's anemia.

A patient with a history of melanoma presents with worsening fatigue, left axillary lymphadenopathy, and a new skin lesion. Which nursing intervention is most appropriate to prioritize at this time?

B) Prepare the patient for the sentinel lymph node biopsy procedure.

A) Educate the patient on self-examination techniques for skin changes.

B) Prepare the patient for the sentinel lymph node biopsy procedure.

C) Initiate dietary counseling to address potential nutritional deficiencies.

D) Administer antipyretics to manage the patient's elevated temperature.

A patient undergoing immunotherapy for metastatic melanoma presents with new-onset fatigue and mild skin reactions. Which nursing intervention is most appropriate to prioritize for managing these symptoms?

B) Educate the patient about the importance of hydration and moisturizing skin.

A) Schedule a blood transfusion to address the fatigue.

B) Educate the patient about the importance of hydration and moisturizing skin.

C) Administer antihistamines to reduce skin reactions.

D) Suggest the patient increase physical activity to combat fatigue.

A patient with metastatic melanoma has started immunotherapy. The oncology nurse is providing education about potential side effects. Which patient statement indicates a need for further teaching?

B) 'If I feel excessively tired, I can skip my next appointment until I feel better.'

A) 'I will report any new skin rashes to my healthcare provider immediately.'

B) 'If I feel excessively tired, I can skip my next appointment until I feel better.'

C) 'I understand that I need to monitor for any signs of infection, such as fever.'

D) 'I will follow the dietary modifications to help manage my anemia.'

A patient undergoing immunotherapy for metastatic melanoma presents with increased fatigue, a mild rash, and a decline in hemoglobin levels despite iron supplementation. Which nursing intervention is most appropriate to address the patient's symptoms?

B) Administer a low-dose corticosteroid regimen as prescribed.

A) Increase the patient's fluid intake to address potential dehydration.

B) Administer a low-dose corticosteroid regimen as prescribed.

C) Initiate a high-protein diet to improve hemoglobin levels.

D) Encourage the patient to engage in daily physical exercise to reduce fatigue.

A patient undergoing immunotherapy for metastatic melanoma presents with increased fatigue, a mild rash, and a decline in hemoglobin levels. Laboratory tests show mild elevation in liver transaminases. Which nursing intervention should be prioritized to address the potential complications of the treatment?

D) Monitor the patient's liver function tests closely and report any significant changes.

A) Encourage the patient to increase fluid intake to manage potential dehydration.

B) Educate the patient on the importance of adhering to the prescribed corticosteroid regimen.

C) Recommend the patient to increase dietary intake of iron-rich foods to address anemia.

D) Monitor the patient's liver function tests closely and report any significant changes.

A patient undergoing immunotherapy presents with persistent fatigue, a rash, and new-onset anemia. The healthcare team suspects immune-mediated hemolytic anemia and plans to increase the corticosteroid dose while awaiting further diagnostic tests. As the nurse, what is the most important clinical sign to monitor in this patient that could indicate a worsening condition?

C) Slight decrease in blood pressure

A patient undergoing immunotherapy for cancer treatment presents with increased fatigue and a further decline in hemoglobin levels, despite dietary adjustments and iron supplementation. The oncology team suspects immune-mediated hemolytic anemia. As a nurse, what is the most appropriate nursing intervention to prioritize in this situation?

B) Monitor the patient's vital signs closely and report any significant changes promptly.

A) Encourage the patient to continue iron supplementation and increase dietary iron intake.

B) Monitor the patient's vital signs closely and report any significant changes promptly.

C) Educate the patient on the importance of rest and energy conservation techniques to manage fatigue.

D) Ensure readiness for possible blood transfusion by obtaining a type and crossmatch.

melanoma - Nursing Case Study

Pathophysiology

• Primary mechanism: Melanoma arises from the malignant transformation of melanocytes, primarily due to DNA damage from ultraviolet (UV) radiation. This damage leads to mutations in genes controlling cell growth, such as BRAF and NRAS, promoting uncontrolled cell proliferation.

• Secondary mechanism: The evasion of apoptotic pathways is crucial, where melanoma cells resist programmed cell death. Mutations in the tumor suppressor gene p53 and dysregulation of apoptotic proteins like Bcl-2 contribute to this survival advantage.

• Key complication: Metastasis is a significant concern, as melanoma can quickly spread to lymph nodes and distant organs. This dissemination is facilitated by altered cell adhesion molecules and the ability to invade surrounding tissues, complicating treatment and prognosis.

Patient Profile

Demographics:

45-year-old female, outdoor construction worker

History:

• Key past medical history: History of severe sunburns, family history of melanoma

• Current medications: Hormone replacement therapy, ibuprofen as needed for pain

• Allergies: Penicillin

Current Presentation:

• Chief complaint: New, rapidly growing mole with irregular border on the left forearm

• Key symptoms: Itching and occasional bleeding from the mole, fatigue, mild lymphadenopathy in left axilla

• Vital signs: Blood pressure 145/90 mmHg, heart rate 95 bpm, respiratory rate 22 breaths per minute, temperature 99.1°F (37.3°C)

Section 1

New Diagnostic Results:

Following the initial assessment, the patient underwent a biopsy of the suspicious mole on her left forearm. The histopathological examination confirmed a diagnosis of invasive melanoma, classified as Stage II due to the tumor's thickness and ulceration but with no evidence of distant metastasis at this point. Additional imaging studies, including an ultrasound of the left axilla, revealed enlarged lymph nodes, suggesting possible lymphatic involvement. A sentinel lymph node biopsy is scheduled to determine the extent of regional spread. Blood tests indicated mild anemia, potentially contributing to her reported fatigue, with hemoglobin levels at 11.0 g/dL, slightly below the normal range. Liver function tests and serum lactate dehydrogenase (LDH) levels are within normal limits, providing some reassurance that there is no current hepatic involvement or significant tumor burden.

These diagnostic results prompted a multidisciplinary discussion to formulate a comprehensive treatment plan. Given the confirmed diagnosis and possible lymphatic involvement, the oncology team is considering a combination of surgical excision with wide local margins and sentinel lymph node dissection. Immunotherapy or targeted therapy may be discussed as adjuvant treatments, particularly if the sentinel lymph node biopsy indicates metastasis. The patient is counseled on the potential side effects and the importance of regular follow-up to monitor for recurrence or further spread. This plan is crucial for addressing the melanoma's aggressive nature and improving the patient's prognosis, underscoring the need for timely intervention.

Section 2

During the follow-up appointment, the patient presents with new symptoms of worsening fatigue and a noticeable swelling in her left axillary region, accompanied by mild discomfort. Upon examination, the left axilla shows increased lymphadenopathy with palpable, firm lymph nodes, suggesting progression. The patient also reports a new patch of skin discoloration and pruritus on her lower back. Vital signs reveal a stable blood pressure at 120/78 mmHg, heart rate of 82 bpm, respiratory rate of 18 breaths per minute, and a slightly elevated temperature of 100.1°F, indicating possible inflammatory or infectious processes.

Given these developments, the healthcare team raises concerns about potential lymphatic spread or local recurrence. An urgent ultrasound of the axillary and lower back regions is ordered to assess the progression and possible new sites of involvement. The oncologist recommends an expedited sentinel lymph node biopsy to evaluate suspected metastasis and a dermatology consult for the new skin lesion. Concurrently, the patient’s anemia persists, with hemoglobin levels declining slightly to 10.5 g/dL, prompting consideration of further investigation into possible etiologies, including chronic disease or nutritional deficiencies. The plan includes a thorough dietary assessment and supplementation if necessary.

These evolving complications necessitate a timely reassessment of the treatment strategy. The potential for lymphatic dissemination increases the need for prompt intervention. The oncology team is prepared to adjust the current treatment plan, potentially advancing to systemic therapies such as immunotherapy, depending on biopsy results. This situation underscores the importance of vigilant monitoring, timely diagnostic testing, and flexible treatment approaches to manage the aggressive nature of melanoma and address the patient's emerging needs.

Section 3

The new diagnostic results from the ultrasound reveal significant findings. The axillary ultrasound highlights multiple enlarged lymph nodes with irregular borders and increased vascularity, raising concerns for metastatic involvement. The lower back ultrasound shows a subcutaneous mass beneath the discolored skin patch, suggestive of a possible cutaneous metastasis. These findings corroborate the clinical suspicion of disease progression, prompting further evaluation. The sentinel lymph node biopsy confirms the presence of metastatic melanoma cells in the axillary nodes. Additionally, the dermatology consult identifies the skin lesion on the lower back as consistent with a superficial spreading melanoma, necessitating immediate intervention.

In light of these results, the oncology team convenes to revise the treatment plan. The patient's declining hemoglobin levels, now at 10.2 g/dL, are attributed to chronic disease anemia, compounded by the cancer's systemic effects. The decision is made to initiate immunotherapy, aiming to harness the patient’s immune system to target and destroy melanoma cells. The team emphasizes the need for close monitoring of the patient's response to this treatment, considering potential side effects such as fatigue, skin reactions, and immune-mediated events. A nutritional support plan, including iron supplementation and dietary modifications, is also implemented to address the anemia and support overall health.

As the patient begins this new phase of her treatment journey, the healthcare team remains vigilant in assessing her response. Regular follow-up appointments are scheduled to monitor her clinical status, evaluate the effectiveness of the immunotherapy, and adjust the plan as necessary. The patient is educated on recognizing signs of potential complications and encouraged to report any new symptoms promptly. This proactive approach ensures that emerging issues can be addressed swiftly, maximizing the potential for a favorable outcome in managing her melanoma.

Section 4

Several weeks into the immunotherapy treatment, the patient presents for a follow-up appointment with new concerns. She reports experiencing increased fatigue and a mild rash on her arms and torso. Upon initial assessment, her vital signs reveal a slight increase in heart rate at 98 beats per minute, while her blood pressure remains stable at 118/76 mmHg. Her temperature is within normal limits, indicating no immediate signs of infection. However, laboratory tests reveal a further decline in hemoglobin levels to 9.8 g/dL, suggesting a worsening of her anemia despite ongoing iron supplementation. Additionally, liver function tests show a mild elevation in transaminases, raising concerns for potential hepatotoxicity, a known side effect of immunotherapy.

Given these findings, the oncology team deliberates on the potential causes of the patient's current symptoms. The rash and fatigue are likely immune-mediated effects of the immunotherapy, necessitating a careful balance between continuing treatment and managing side effects. The team decides to initiate a low-dose corticosteroid regimen to address the rash and monitor liver function closely. Adjustments to the nutritional support plan are also made, increasing the emphasis on foods rich in vitamin B12 and folate to further support hematopoiesis and counteract the anemia.

The patient is advised to maintain close communication with the healthcare team and report any further changes in her condition. A follow-up appointment is scheduled in two weeks to reassess her response to the interventions and make any necessary adjustments to her treatment regimen. This vigilant monitoring and proactive management underscore the complexity of her case, requiring ongoing clinical reasoning to navigate the challenges of metastatic melanoma and its treatment.

Section 5

Two weeks later, the patient returns for her follow-up appointment, where she reports some improvement in the rash, though it has not completely resolved. She continues to experience significant fatigue, which is now impacting her daily activities. Upon physical examination, the rash appears less inflamed, with reduced erythema and fewer raised lesions, suggesting a partial response to the low-dose corticosteroid regimen. However, her conjunctivae appear more pale than before, indicating a potential exacerbation of her anemia. Her vital signs show a slight decrease in blood pressure to 112/74 mmHg and an unchanged heart rate of 98 beats per minute, while her temperature remains normal.

Laboratory results from this visit reveal a further decline in hemoglobin to 9.2 g/dL, despite dietary adjustments and iron supplementation. Liver function tests indicate a continued mild elevation in transaminases, though not significantly worse than previous levels. These findings prompt the oncology team to consider the possibility of immune-mediated hemolytic anemia as a complication of the ongoing immunotherapy, warranting additional investigation and potential modification of her treatment plan.

Given the persistence of her symptoms and the laboratory findings, the team deliberates on the next steps. They decide to increase the corticosteroid dose to more aggressively address the potential immune-mediated processes contributing to her anemia and rash. Additionally, they plan to conduct a peripheral blood smear and reticulocyte count to further evaluate the nature of her anemia. The patient is instructed to monitor her symptoms closely and contact the healthcare team if she experiences any new or worsening issues, as timely intervention will be crucial in managing these complications. A follow-up visit is scheduled in one week to reassess her condition and determine the effectiveness of the adjusted treatment strategy.